Concord Medical Services Holdings Limited C2CA.F Stock
Concord Medical Services Holdings Limited Price Chart
Concord Medical Services Holdings Limited C2CA.F Financial and Trading Overview
Contents
- Concord Medical Services Holdings Limited Price Chart
- Concord Medical Services Holdings Limited C2CA.F Financial and Trading Overview
- Valuation Measures
- Trading Information
- Financial Highlights
- Profile of Concord Medical Services Holdings Limited
- Q&A For Concord Medical Services Holdings Limited Stock
Concord Medical Services Holdings Limited stock price | 0.56 EUR |
Previous Close | 1.25 EUR |
Open | 1.21 EUR |
Bid | 1.21 EUR x 100000 |
Ask | 1.29 EUR x 100000 |
Day's Range | 1.21 - 1.21 EUR |
52 Week Range | 0.94 - 1.98 EUR |
Volume | 500 EUR |
Avg. Volume | 0 EUR |
Market Cap | 57.36M EUR |
Beta (5Y Monthly) | -0.232042 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -1.38 EUR |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | December 23, 2015 |
1y Target Est | N/A |
C2CA.F Valuation Measures
Enterprise Value | 7.01B EUR |
Trailing P/E | N/A |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 0.1215034 |
Price/Book (mrq) | N/A |
Enterprise Value/Revenue | 14.854 |
Enterprise Value/EBITDA | -17.45 |
Trading Information
Concord Medical Services Holdings Limited Stock Price History
Beta (5Y Monthly) | -0.232042 |
52-Week Change | -29.76% |
S&P500 52-Week Change | 20.43% |
52 Week High | 1.98 EUR |
52 Week Low | 0.94 EUR |
50-Day Moving Average | 1.19 EUR |
200-Day Moving Average | 1.39 EUR |
C2CA.F Share Statistics
Avg. Volume (3 month) | 0 EUR |
Avg. Daily Volume (10-Days) | 0 EUR |
Shares Outstanding | 43.42M |
Float | 13.3M |
Short Ratio | N/A |
% Held by Insiders | 17.99% |
% Held by Institutions | 0.37% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | December 31, 2022 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | -103.72% |
Operating Margin (ttm) | -111.21% |
Gross Margin | -32.28% |
EBITDA Margin | -85.12% |
Management Effectiveness
Return on Assets (ttm) | -5.36% |
Return on Equity (ttm) | -32.31% |
Income Statement
Revenue (ttm) | 472.08M EUR |
Revenue Per Share (ttm) | 10.81 EUR |
Quarterly Revenue Growth (yoy) | 12.00% |
Gross Profit (ttm) | -152409000 EUR |
EBITDA | -401860992 EUR |
Net Income Avi to Common (ttm) | -489660992 EUR |
Diluted EPS (ttm) | -1.37 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 158.28M EUR |
Total Cash Per Share (mrq) | 3.65 EUR |
Total Debt (mrq) | 3.24B EUR |
Total Debt/Equity (mrq) | 160.74 EUR |
Current Ratio (mrq) | 0.678 |
Book Value Per Share (mrq) | -42.931 |
Cash Flow Statement
Operating Cash Flow (ttm) | -216694000 EUR |
Levered Free Cash Flow (ttm) | -747450112 EUR |
Profile of Concord Medical Services Holdings Limited
Country | Germany |
State | N/A |
City | Beijing |
Address | Tower A, Global Trade Center |
ZIP | 100013 |
Phone | 86 10 5903 6688 |
Website | https://www.concordmedical.com |
Industry | Medical Care Facilities |
Sector(s) | Healthcare |
Full Time Employees | 918 |
Concord Medical Services Holdings Limited, together its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People's Republic of China. The company operates in two segments, Network and Hospital. Its services include linear accelerators and external beam radiotherapy, proton therapy system, gamma knife radiosurgery, head gamma knife system, and diagnostic imaging services. The company's other treatments and diagnostic services comprise positron emission tomography-computed tomography and magnetic resonance imaging scanners. In addition, it provides clinical support services, such as developing treatment protocols for doctors, and organizing joint diagnosis between doctors in its network and clinical research, as well as helps to recruit and determine the compensation of doctors and other medical personnel. Further, the company offers radiotherapy and diagnostic equipment leasing, management services, and premium cancer and proton treatment services to hospitals, as well as teleconsultation and medical information technology services; and sells medical equipment. Additionally, it operates specialty cancer hospitals, which offer radiotherapy services, diagnostic imaging services, chemotherapy, and surgery. The company was founded in 1997 and is headquartered in Beijing, the People's Republic of China.
Q&A For Concord Medical Services Holdings Limited Stock
What is a current C2CA.F stock price?
Concord Medical Services Holdings Limited C2CA.F stock price today per share is 0.56 EUR.
How to purchase Concord Medical Services Holdings Limited stock?
You can buy C2CA.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Concord Medical Services Holdings Limited?
The stock symbol or ticker of Concord Medical Services Holdings Limited is C2CA.F.
Which industry does the Concord Medical Services Holdings Limited company belong to?
The Concord Medical Services Holdings Limited industry is Medical Care Facilities.
How many shares does Concord Medical Services Holdings Limited have in circulation?
The max supply of Concord Medical Services Holdings Limited shares is 45.54M.
What is Concord Medical Services Holdings Limited Price to Earnings Ratio (PE Ratio)?
Concord Medical Services Holdings Limited PE Ratio is now.
What was Concord Medical Services Holdings Limited earnings per share over the trailing 12 months (TTM)?
Concord Medical Services Holdings Limited EPS is -1.38 EUR over the trailing 12 months.
Which sector does the Concord Medical Services Holdings Limited company belong to?
The Concord Medical Services Holdings Limited sector is Healthcare.